June 25, 2021
According to the research report titled ‘Global Incontinence and Ostomy Care Products Market Size study, by Type (Incontinence Care Products and Ostomy Care Products) and Regional Forecasts 2020-2027’, available with Market Study Report, global incontinence and ostomy care products market size was worth USD 14.75 billion in 2019 and is expected to record a CAGR of 5.1% over 2021-2027, subsequently amassing USD 21.96 billion valuation by the end of the forecast period.
Increasing pervasiveness of urologic disorders is primarily driving global incontinence and ostomy care products market growth, cites the study.
Apparently, Urologyhealth.org cites that quarter to a third of women and men in the United States suffer from urine incontinence, and the World Health Organization (WHO) stated that the prevalence is twice as high in older women as in older males.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3793432/
For the unfamiliar, incontinence and ostomy care products are used in medical treatments or surgeries for people who have lost bladder control or who suffer from involuntary urine leakage.
Rising healthcare expenditure for curative care of patients by opting for surgeries is enhancing the overall market outlook. According to ama-assn.org, health expenditure in the United States increased by 4.6%, reaching USD 11,172 per capita in 2018, up from USD 10,680.69 in 2017. Similar developments in the field are creating lucrative prospects for businesses operating in the domain.
Moreover, increasing investments in healthcare vertical and planned alliances between manufacturers and hospitals are further driving worldwide incontinence and ostomy care products industry expansion.
On the downside, stringent regulations related to surgeries and high manufacturing costs are likely to hamper the industry remuneration over the study period.
Considering the regional landscape, Europe currently holds significant portion of global incontinence and ostomy care products market share, attributable to presence of well-established healthcare infrastructure, key players base, and increasing stoma patients due to Crohn’s disease in the region.
On the other hand, Asia Pacific industry is slated to grow substantially over the coming years, creditable to rising cognizance regarding medical solutions, presence of various nursing centers & medical institutes, and rising disposable income.
Major contenders in global incontinence and ostomy care products market are Salts Healthcare Ltd., Domtar Corporation, Welland Medical Ltd., ConvaTec Group plc, Unicharm Corporation, Hollister Incorporated, B. Braun Melsungen AG, KCWW (Kimberly-Clark Corporation), Essity (Svenska Cellulosa Aktiebolaget), and Coloplast Corporation.